5202
A. Kumar, S.S. Chimni / Tetrahedron 69 (2013) 5197e5204
OH), 6.77e6.87 (m, 2H, ArH), 7.13e7.25 (m, 2H, ArH), 10.17 (s, 1H,
NH); 13C NMR (75 MHz, DMSO-d6):
24.4, 26.6, 26.7, 41.4, 57.3, 73.9,
109.4, 120.8, 124.7, 128.5, 130.8, 143.4, 178.6, 209.1; m/z (TOF):
268.9803 (MþþNa).
excess: 77% of syn diastereomer determined by HPLC (Diacel
d
Chiralpak AS-H; hexane/i-PrOH 93:7; flow rate 1 mL/min;
l
¼254 nm, tR (syn, major)¼33.3 min, tR (syn, minor)¼46.2 min); 1H
NMR (300 MHz, CDCl3): d 1.57e1.68 (m, 4H, CH2), 1.89e2.04 (m, 2H,
CH2), 2.30e2.49 (m, 2H, CH2), 2.97e3.00 (m, 1H, CH), 4.18e4.24 (m,
1H, eCHaHbeCH]CH2), 4.38e4.45 (m, 1H, eCHaHbeCH]CH2),
4.76 (br, 1H, OH), 5.21e5.34 (m, 2H, eCH]CH2), 5.82e5.86 (m, 1H,
eCH]CH2), 6.80e6.83 (d, J¼7.5 Hz, 1H, ArH), 7.02e7.07 (m, 1H,
4.2.2. (R)-5-Chloro-3-hydroxy-3-((S)-20-oxocyclohexyl)indolin-2-
one4a (4b). White solid; yield¼94%; mp¼182e184 ꢀC; Rf (60%
EtOAc/hexane) 0.27; ½a D25
þ62 (c 0.1, MeOH); syn/anti¼94:6; en-
ꢄ
antiomeric excess: 79% of syn diastereomer determined by HPLC
ArH), 7.27e7.35 (m, 2H, ArH); 13C NMR (75 MHz, CDCl3):
d 24.4,
(Diacel Chiralpak IB; hexane/i-PrOH 80:20; flow rate 0.5 mL/min;
l
25.9, 27.0, 41.9, 42.3, 55.6, 76.7,109.2,117.6,122.7,124.0,128.8,129.7,
131.2, 143.6, 176.5, 211.4; HRMS (ESI) m/z: [MþþNa] calcd for
C17H19NO3 308.1263; found 308.1230.
¼254 nm, tR (syn, major)¼21.0 min, tR (syn, minor)¼28.2 min); 1H
NMR (300 MHz, DMSO-d6):
d 1.50e2.04 (m, 6H, CH2); 2.27e2.54
(m, 2H, CH2), 3.05e3.11 (m, 1H, CH), 5.99 (s, 1H, OH), 6.79 (d,
J¼8.1 Hz, 1H, ArH), 7.17e7.23 (m, 2H, ArH), 10.34 (s, 1H, NH); 13C
4.2.8. (R)-1-Allyl-5-fluoro-3-hydroxy-3-((S)-20-oxocyclohexyl)in-
dolin-2-one (4h). Sticky solid; yield¼93%; Rf (50% EtOAc/hexane)
NMR (75 MHz, DMSO-d6):
d 24.9, 27.1, 41.9, 57.8, 74.4, 111.2, 125.2,
128.7, 133.3, 142.8, 178.8, 209.7; m/z (TOF): 302.0302 (MþþNa).
0.46; ½a 2D5
þ34 (c 0.1, MeOH); syn/anti¼95:5; enantiomeric excess:
ꢄ
91% of syn diastereomer determined by HPLC (Diacel Chiralpak OD-
4.2.3. (R)-5-Bromo-3-hydroxy-3-((S)-20-oxocyclohexyl)indolin-2-
H; hexane/i-PrOH 95:5; flow rate 1 mL/min;
l
¼254 nm, tR (syn,
one4a (4c). White solid; yield¼95%; mp¼187e189 ꢀC; Rf (60%
major)¼19.4 min, tR (syn, minor)¼23.0 min); 1H NMR (300 MHz,
EtOAc/hexane) 0.28; ½a D25
ꢄ
þ71 (c 0.1, MeOH); syn/anti¼91:9; en-
CDCl3): d 1.57e168 (m, 4H, CH2), 1.94e2.14 (m, 2H, CH2),
antiomeric excess: 78% of syn diastereomer determined by HPLC
2.25e2.46 (m, 2H, CH2), 2.97e3.03 (m, 1H, CH), 4.15e4.22 (m,
1H, eCHaHbeCH]CH2), 4.37e4.44 (m, 1H, eCHaHbeCH]CH2), 4.74
(br s, 1H, OH), 5.23e5.34 (m, 2H, eCH]CH2), 5.77e5.90 (m,
1H, eCH]CH2), 6.73e6.77 (m, 1H, ArH), 6.95e7.02 (m, 1H, ArH),
(Diacel Chiralpak AD-H; hexane/i-PrOH 92:8; flow rate 0.8 mL/min;
l
¼254 nm, tR (syn, major)¼71.9 min, tR (syn, minor)¼54.9 min); 1H
NMR (300 MHz, DMSO-d6): d 1.47e2.04 (m, 6H, CH2), 2.26e2.58 (m,
2H, CH2), 3.04e3.11 (m, 1H, CH), 5.98 (s, 1H, OH), 6.74 (d, J¼8.1 Hz,
7.07e7.11 (m, 1H, ArH); 13C NMR (75 MHz, CDCl3):
d 24.4, 26.1, 27.1,
1H, ArH), 7.28e7.42 (m, 2H, ArH), 10.34 (s, 1H, NH); 13C NMR
41.9, 42.5, 55.7, 76.8, 109.9, 112.5, 116.0, 131.0, 139.6, 157.6, 160.8,
176.3, 211.2; HRMS (ESI) m/z: [MþþNa] calcd for C17H18FNNaO3
326.1168; found 326.1264.
(75 MHz, DMSO-d6):
d 24.9, 27.1, 27.2, 41.9, 57.9, 74.4, 111.9, 113.0,
127.9, 131.8, 133.8, 143.3, 178.7, 209.8; m/z (TOF): 347.9740
(MþþNa).
4.2.9. (R)-1-Allyl-5-chloro-3-hydroxy-3-((S)-20-oxocyclohexyl)in-
4.2.4. (R)-3-Hydroxy-5-nitro-3-((S)-20-oxocyclohexyl)indolin-2-one
dolin-2-one (4i). White solid; yield¼94%; mp¼149e151 ꢀC; Rf (50%
(4d). White solid; yield¼90%; mp¼198e200 ꢀC; Rf (50% EtOAc/
EtOAc/hexane) 0.41; ½a D25
þ41 (c 0.1, MeOH); syn/anti¼91:9; en-
ꢄ
hexane) 0.21; ½a D25
ꢄ
þ65 (c 0.1, MeOH); 1H NMR (400 MHz, DMSO-
antiomeric excess: 90% of syn diastereomer determined by HPLC
d6):
d
1.60e1.93 (m, 3H, CH2); 2.01e2.40 (m, 4H, CH2), 2.75e2.79
(Diacel Chiralpak AD-H; hexane/i-PrOH 95:5; flow rate 1 mL/min;
(m, 1H, CH2), 3.22e3.30 (m, 1H, CH), 6.20 (s, 1H, OH), 6.93e7.01 (m,
l
¼254 nm, tR (syn, major)¼39.5 min, tR (syn, minor)¼47.3 min); 1H
1H, ArH), 8.06e8.22 (m, 2H, ArH), 10.81 (s, 1H, NH); 13C NMR
NMR (300 MHz, CDCl3): 1.56e1.77 (m, 4H, CH2), 1.93e2.13 (m, 2H,
CH2), 2.25e2.47 (m, 2H, CH2), 2.97e3.03 (m, 1H, CH), 4.15e4.22 (m,
1H, eNeCHaHbeCH]CH2), 4.37e4.44 (m, 1H, eNeCHaHbeCH]
CH2), 4.67 (s, 1H, OH), 5.22e5.33 (m, 2H, eCH]CH2), 5.77e5.88 (m,
1H, eCH]CH2), 6.73e6.76 (m, 1H, ArH), 7.24e7.32 (m, 2H, ArH);
(100 MHz, DMSO-d6): d 209.3, 179.4, 150.1, 141.8, 131.5, 125.9, 120.3,
109.4, 73.8, 57.8, 41.6, 27.7, 26.9, 24.8; m/z (TOF): 313.0865
(MþþNa).
4.2.5. (R)-5-Bromo-3-hydroxy-1-methyl-3-((S)-20-oxocyclohexy)in-
13C NMR (75 MHz, CDCl3):
d 24.5, 25.3, 27.2, 41.9, 42.5, 55.7, 76.5,
dolin-2-one (4e). White solid; yield¼92%; mp¼164e166 ꢀC; Rf (50%
110.8, 115.4, 118.9, 128.4, 131.8, 133.4, 142.7, 176.0, 211.5; HRMS (ESI)
EtOAc/hexane) 0.42; ½a D25
ꢄ
þ45 (c 0.1, MeOH); syn/anti¼90:10; en-
m/z: [MþþNa] calcd for C17H18ClNNaO3 342.0873; found 342.0874.
antiomeric excess: 88% of syn diastereomer determined by HPLC
(Diacel Chiralpak OD-H; hexane/i-PrOH 97.5:2.5; flow rate 1 mL/
4.2.10. (R)-1-Allyl-5-bromo-3-hydroxy-3-((S)-20-oxocyclohexyl)in-
min;
l
¼254 nm, tR (syn, major)¼54.7 min, tR (syn, minor)¼
dolin-2-one (4j). White solid; yield¼94%; Rf (50% EtOAc/hexane)
68.5 min); 1H NMR (300 MHz, CDCl3):
d
1.63e1.59 (m, 4H, CH2),
0.49; mp¼158e160 ꢀC; ½a D25
þ40 (c 0.1, MeOH); syn/anti¼89:11;
ꢄ
2.14e1.92 (m, 3H, CH2), 2.44e2.28 (m, 1H, CH2), 2.97e3.01 (m, 1H,
CH), 3.16 (s, 3H, NCH3), 4.70 (br s, 1H, OH), 6.71 (d, J¼8.7 Hz, 1H,
enantiomeric excess: 90% of syn diastereomer determined by HPLC
(Diacel Chiralpak OD-H; hexane/i-PrOH 95:5; flow rate 1 mL/min;
ArH), 7.43e7.45 (m, 2H, ArH); 13C NMR (75 MHz, CDCl3):
d
24.4,
l
¼254 nm, tR (syn, major)¼19.6 min, tR (syn, minor)¼27.0 min); 1H
26.0, 26.2, 27.0, 42.0, 55.7, 76.5, 109.7, 115.4, 127.4, 130.8, 132.6,
NMR (300 MHz, CDCl3): d 1.52e1.87 (m, 4H, CH2), 1.89e2.18 (m, 2H,
143.5, 176.2, 211.2; m/z (TOF): 360.0315 (MþþNa).
CH2), 2.22e2.46 (m, 2H, CH2), 4.21e4.23 (m, 1H, NeCHaHbeCH]
CH2), 4.37e4.44 (m, 1H, NeCHaHbeCH]CH2), 4.75 (s, 1H, OH),
5.22e5.33 (m, 2H, eCH]CH2), 5.72e5.83 (m, 1H, eCH]CH2),
6.68e6.72 (m, 1H, ArH), 7.39e7.59 (m, 2H, ArH); 13C NMR (75 MHz,
4.2.6. (R)-3-Hydroxy-1-methyl-3-((S)-20-oxocyclohex-10-yl)indolin-
2-one5h (4f). White solid; yield¼92%; mp¼144e146 ꢀC; Rf (50%
EtOAc/hexane) 0.40; ½a D25
ꢄ
þ35 (c 0.1, MeOH); 1H NMR (400 MHz,
CDCl3): d 24.5, 25.2, 27.1, 41.9, 42.4, 55.9, 76.4, 110.8, 115.4, 117.9,
CDCl3):
d
1.55e1.75 (m, 4H, CH2), 1.88e2.07 (m, 2H, CH2), 2.25e2.47
127.4, 130.8, 132.4, 142.7, 176.0, 211.0; HRMS (ESI) m/z:
(m, 2H, CH2), 2.91e3.01 (m, 1H, CH), 3.19 (s, 3H, NCH3), 4.86 (br s,
1H, OH), 6.82 (d, J¼5.7 Hz, 1H, ArH), 7.04e7.08 (m, 1H, ArH),
[MþþNaþ2H] calcd. for C17H18BrNO3 388.0524; found 388.0512.
7.27e7.35 (m, 2H, ArH); 13C NMR (100 MHz, CDCl3):
d
24.5, 26.0,
4.2.11. (R)-1-Allyl-5-iodo-3-hydroxy-3-((S)-20-oxocyclohexyl)in-
26.1, 27.1, 42.1, 55.5, 76.7, 108.3, 122.8, 123.9, 128.8, 129.9, 144.4,
dolin-2-one (4k). White solid; yield¼91%; mp¼135e137 ꢀC; Rf (50%
176.6, 211.7; m/z (ESI): 256.2 (MþþH).
EtOAc/hexane) 0.51; ½a D25
þ43 (c 0.1, MeOH); syn/anti¼91:9; en-
ꢄ
antiomeric excess: 88% of syn diastereomer determined by HPLC
4.2.7. (R)-1-Allyl–3-hydroxy-3-((S)-20-oxocyclohexyl)indolin-2-one
(4g). White solid; yield¼90%; mp¼109e111 ꢀC; Rf (50% EtOAc/
(Diacel Chiralpak OD-H; hexane/i-PrOH 93:7; flow rate 1 mL/min;
l
¼254 nm, tR (syn, major)¼19.8 min, tR (syn, minor)¼37.9 min); 1H
hexane) 0.45; ½a D25
ꢄ
þ37 (c 0.1, MeOH); syn/anti¼96:4; enantiomeric
NMR (300 MHz, CDCl3): d 1.60e1.80 (m, 4H, CH2); 1.92e2.14 (m, 2H,